244 related articles for article (PubMed ID: 29514948)
1. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.
Cortese R; Magnollay L; Tur C; Abdel-Aziz K; Jacob A; De Angelis F; Yiannakas MC; Prados F; Ourselin S; Yousry TA; Barkhof F; Ciccarelli O
Neurology; 2018 Apr; 90(14):e1183-e1190. PubMed ID: 29514948
[TBL] [Abstract][Full Text] [Related]
2. Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging.
Cortese R; Prados Carrasco F; Tur C; Bianchi A; Brownlee W; De Angelis F; De La Paz I; Grussu F; Haider L; Jacob A; Kanber B; Magnollay L; Nicholas RS; Trip A; Yiannakas M; Toosy AT; Hacohen Y; Barkhof F; Ciccarelli O
Neurology; 2023 Jan; 100(3):e308-e323. PubMed ID: 36192175
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
[TBL] [Abstract][Full Text] [Related]
4. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
Sinnecker T; Clarke MA; Meier D; Enzinger C; Calabrese M; De Stefano N; Pitiot A; Giorgio A; Schoonheim MM; Paul F; Pawlak MA; Schmidt R; Kappos L; Montalban X; Rovira À; Evangelou N; Wuerfel J;
JAMA Neurol; 2019 Dec; 76(12):1446-1456. PubMed ID: 31424490
[TBL] [Abstract][Full Text] [Related]
6. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
Ciotti JR; Eby NS; Brier MR; Wu GF; Chahin S; Cross AH; Naismith RT
Mult Scler; 2022 Jan; 28(1):49-60. PubMed ID: 33870786
[TBL] [Abstract][Full Text] [Related]
7. An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue.
Tackley G; Kong Y; Minne R; Messina S; Winkler A; Cavey A; Everett R; DeLuca GC; Weir A; Craner M; Tracey I; Palace J; Stagg CJ; Emir U
Neuroimage; 2021 Sep; 238():118225. PubMed ID: 34062267
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility-weighted image features in AQP4-negative-NMOSD versus MS.
Gao C; Su L; Li H; Song T; Liu Y; Duan Y; Shi FD
Mult Scler Relat Disord; 2024 Feb; 82():105406. PubMed ID: 38176283
[TBL] [Abstract][Full Text] [Related]
9. Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
Carnero Contentti E; Marques VD; Soto de Castillo I; Tkachuk V; Barreira AA; Caride A; Castillo MC; Cristiano E; de Aquino Cruz C; Braga Diégues Serva G; Santos ACD; Labarca R; Lavigne Moreira C; López PA; Miguez J; Molina O; Pettinicchi JP; Rojas JI
Mult Scler; 2020 Jul; 26(8):945-954. PubMed ID: 31124748
[TBL] [Abstract][Full Text] [Related]
10. Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques.
Zhang N; Sun J; Wang Q; Qin W; Zhang X; Qi Y; Yang L; Shi FD; Yu C
Mult Scler Relat Disord; 2020 Jun; 41():102035. PubMed ID: 32200338
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
[TBL] [Abstract][Full Text] [Related]
12. χ-Separation Imaging for Diagnosis of Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder.
Kim W; Shin HG; Lee H; Park D; Kang J; Nam Y; Lee J; Jang J
Radiology; 2023 Apr; 307(1):e220941. PubMed ID: 36413128
[TBL] [Abstract][Full Text] [Related]
13. High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status.
Bertsch-Gout M; Loeb R; Finch AK; Javed A; Bernard J
J Neurol Sci; 2018 Jan; 384():61-66. PubMed ID: 29249380
[TBL] [Abstract][Full Text] [Related]
14. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
[TBL] [Abstract][Full Text] [Related]
15. Sudden hearing loss as the initial symptom in Japanese patients with multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Tanaka M; Tanaka K
J Neuroimmunol; 2016 Sep; 298():16-8. PubMed ID: 27609270
[TBL] [Abstract][Full Text] [Related]
16. Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder.
Wang Y; Zhou Y; Sun X; Lu T; Wei L; Fang L; Chen C; Huang Q; Hu X; Lu Z; Peng L; Qiu W
Neuroimmunomodulation; 2016; 23(5-6):352-358. PubMed ID: 28445879
[TBL] [Abstract][Full Text] [Related]
17. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
[TBL] [Abstract][Full Text] [Related]
18. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
Yan Y; Li Y; Fu Y; Yang L; Su L; Shi K; Li M; Liu Q; Borazanci A; Liu Y; He Y; Bennett JL; Vollmer TL; Shi FD
Sci China Life Sci; 2016 Dec; 59(12):1270-1281. PubMed ID: 26920678
[TBL] [Abstract][Full Text] [Related]
20. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
